Systematic reviews on eczema
March 2021: This resource is now archived and no longer being updated.
We recommend the database as a comprehensive, searchable database of systematic reviews. The provides an alternative source for atopic dermatitis systematic reviews, browsable by topic.
This page is a mapping by topic of systematic reviews on eczema (atopic eczema) published since the 2000 HTA . The systematic reviews were found in the searches for our Annual Evidence Updates and . Links are given to the PubMed abstract, or the original publication if not in PubMed.
Atopic eczema (© CEBD)
Copyright © 2021 The 糖心原创, on behalf of the Centre of Evidence Based Dermatology. ALL RIGHTS RESERVED.
Please reference this resource (as a web page citation) if you use it for research or publications.
Epidemiology and aetiology
2020
2020
2019
2018
2017
2017
2016
2016
2015
2014
2012
2010
2007 (NICE guideline)
Aetiology, genetic risk factors & biomarkers
Risk factors - maternal & prenatal (see also "Maternal diet" under Prevention)
2021
2021
2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2018
2018
2018
2018
2017
2017
2016
2016
2016
2016
2016
2016
2015
2012
2011
1998
2021
2021
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019 (in German)
2018
2018
2018
2018
2018
2017
2017
2017
2017
2017
2017
2017
2016
2016
2016
2016
2016
2016
2016
2016
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2014
2014
2014
2014 (AAD guideline)
2013
2013
2013
2012
2012
2012
2011
2011
2011
2011
2010
2008
2008
2007 (NICE guideline)
2007
2007
2006
2005
2004
1998
2021
2021
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2019
2019
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2016
2016
2016
2016
2016
2016
2016
2016
2016
2015
2015
2015
2015 (in German)
2015
2014 (AAD guideline)
2014 (AAD guideline)
2014
2011
2011
2011
2010
2010
2008
2007 (NICE guideline)
2007
2007
2006
2005
2003
Diagnosis, evaluation & outcomes
2021
2020
2019
2018
2018
2018
2018
2017
2017
2017
2016
2016
2016
2016
2016
2016
2016
2016
2016
2015
2015
2014 (AAD guideline)
2014
2014
2013
2012
2012
2011
2011 (SIGN guideline)
2008
2007 (NICE guideline)
2007
2006
2004
2003
2000
Disease impact & treatment cost-effectiveness
2020
2020
2020
2020
2020
2020
2020
2020
2019
2019
2018
2018
2018
2018
2018
2017
2017
2017
2017
2017
2017
2017
2016
2016
2016
2016
2016
2016
2016
2016
2016
2014 (AAD guideline)
2008
2008
2008
2007 (NICE guideline)
2003
2020
2020
2019
2019
2018
2018
2017
2017
2017
2016
2016
2016
2016
2016
2016
2015
2015
2012
Prevention
2021
2021
2020
2019
2019
2019 (in Chinese)
2018
2018
2017
2017
2017
2016
2016
2016
2016
2016
2015 (Cochrane Review)
2015
2015
2015
2014
2014
2013
2012 (Cochrane Review)
2012
2012
2012
2011
2011
2011
2011 (SIGN guideline)
2010
2010
2008
2002
2000
2019
2019
2019
2019
2018
2017
2017
2015
2012 (Cochrane Review)
2011
2011
2011 (SIGN guideline) 
2010
2010
2010
2009
2009
2008
2007
2004
2001
2000
Dietary & supplements (for prevention)
2020
2019
2019
2019
2019
2019
2019
2019
2019 (in Chinese)
2018
2018 (Cochrane Review)
2018
2018
2018
2018
2018
2017
2017
2017
2017
2016
2016
2016
2016
2016
2016
2016
2015
2015
2015
2015
2015
2014
2014
2013 (Cochrane Review)
2013
2013
2013
2013
2012 (in Chinese)
2012
2012 (in Chinese)
2012
2011
2011
2011
2011
2011 (SIGN guideline)
2011
2010
2010
2010
2010
2010
2010
2010
2009
2008
2008
2008
2007 (Cochrane Review)
2007
2006 (Cochrane Review)
2006 (Cochrane Review)
2006
2005
2005
2001
2000
Aeroallergen reduction (for prevention)
2017
2015
2014
2014
2011
2008
2021
2021 (Cochrane Review)
2021
2017
2017
2016
2014
2011
Topical treatments
2021
2020
2019
2019
2019
2018
2018
2017
2017
2016
2016
2016
2016
2016
2015
2015 (Cochrane Review)
2015
2015
2014 (AAD guideline)
2014 (AAD guideline)
2012
2011
2011
2011
(SIGN guideline)
2007 (NICE guideline)
2007
2005
2004
2003
2000
Topical calcineurin inhibitors
2020
2019
2016
2016
2016
2016
2016
2015 (Cochrane Review)
2015
2015
2015
2014 (AAD guideline)
2014 (AAD guideline)
2014
2012
2011
2011
2011
2011
2011 (SIGN guideline)
2010
2010
2009
2008
2007 (NICE guideline)
2007 (Cochrane Review)
2007
2007
2006
2005
2005
2004
2003
2000
2021 (Cochrane Review)
2021
2020
2019
2019
2019
2019
2019
2017
2017
2017
2017 (Cochrane Review)
2016
2016
2015
2014 (AAD guideline)
2014 (AAD guideline)
2012
2011
(SIGN guideline)
2009
2007 (NICE guideline)
2000
2020
2019 (Cochrane Review)
2017
2016
2016
2014 (AAD guideline)
(SIGN guideline)
2010 (see 2019 update)
2007 (NICE guideline)
2007
2000
2016
2016
2016
2014 (AAD guideline)
2011 (SIGN guideline)
2010
2007 (NICE guideline)
2006
2020
2020
2020
2019
2019
2019
2018
2017
2016
2016
2016
2016
2015
2015
2014 (AAD guideline)
2014
2012
2010
2007 (NICE guideline)
2007
2000
Systemic treatments
2020
2020 (Cochrane Review)
2020
2018
2017
2016
2016
2014
2014 (AAD guideline)
2007 (NICE guideline)
2007
Systemic immune modulators (conventional, non-biologic)
2021
2020
2020
2020 (Cochrane Review)
2020
2020
2019
2019
2018
2016
2016
2014
2014 (AAD guideline)
2011
2007 (NICE guideline)
2007
2007
2003
2000
Systemic biologic therapies
2021
2021
2021
2020
2020
2020 (Cochrane Review)
2020
2020
2020
2020
2020
2020
2020
2019
2019
2018
2018
2018
2018
2017
2017
2017
2017
2017
2017
2016
2016
2016
2016
2016
New small molecule systemic therapies
2020
2020
2020 (Cochrane Review)
2020
2019
2018
2017
2017
Immunotherapy/desensitisation
2017
2016
2016
2016
2016 (Cochrane Review)
2015
2014
2014 (AAD guideline)
2013
2013
2012
2012
2012
2011
2010
2007 (NICE guideline)
2007
2006
2000
2019 (Cochrane Review)
2016
2016
2014 (AAD guideline)
2011 (SIGN guideline)
2010 (see 2019 update))
2007 (NICE guideline)
2000
Anti-histamine/anti-allergic
2019 (Cochrane Review)
2016
2016
2014 (AAD guideline)
2014
2013 (Cochrane Review)
2012
22011 (SIGN guideline)
2007 (NICE guideline)
2000
Dietary & supplements (for treatment)
2020
2020
2019
2019
2019
2019
2019
2019
2018 (Cochrane Review)
2018
2018
2018
2018
2018
2017
2017
2017
2016
2016
2016
2016
2016
2016
2015
2014
2014
2014 (AAD guideline)
2013
2013
2013 (Cochrane Review)
2012
2012 (Cochrane Review)
2011
2011 (SIGN guideline)
2010
2010
2009
2009
2008 (Cochrane Review)
2008
2008
2008
2008 (Cochrane Review)
2007 (NICE guideline)
2006
2005
2004
2004
2002
2000
Other systemic treatments
2020
2020
2018
2018
2018 (Cochrane Review)
2018
2017
2016
2016
2016
2014
2014 (AAD guideline)
2007 (NICE guideline)
2005
2000
Other treatments
2018
2016
2016
2015
2015
2014
2014 (AAD guideline)
2007 (NICE guideline)
2007
2005
2003
2000
Psychological & educational
2020
2020
2020
2020
2020
2020
2019
2019
2019 (Cochrane Review)
2017
2017
2017
2016
2016
2016
2016
2015
2015
2015
2015
2014 (Cochrane Review)
2014 (AAD guideline)
2012
2011 (SIGN guideline)
2011
2010
2008
2007 (NICE guideline)
2007
2006
2000
Aeroallergen reduction (for treatment)
2016
2016
2015 (Cochrane Review)
2015
2014
2014 (AAD guideline)
(SIGN guideline)
2007 (NICE guideline)
2006
2000
2016
2014 (AAD guideline)
2000
2020
2019 (Cochrane Review)
2016
2016
2014 (AAD guideline)
2013
2011 (SIGN guideline)
2010 (see 2019 update)
2009
2000
Bathing & water softeners
2020
2020
2019 (Cochrane Review)
2019
2018
2017
2016
2016
2016
2015
2014 (AAD guideline)
2019
2018 (in Chinese)
2017
2016
2016
2016
2016
2014
2014 (AAD guideline)
2014
2013
2013 (Cochrane Review)
2012
2011
(SIGN guideline)
2010
2007 (NICE guideline)
2007
2002
2000
Complementary & alternative therapies
2020
2020
2019
2018
2018
2017
2016
2016
2016
2016
2015
2015
2015
2014 (AAD guideline)
2012
2012
2011
2011 (SIGN guideline)
2010
2007 (NICE guideline)
2002
2000